FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma.

about

FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma.

Item

http://www.wikidata.org/entity/Q51770071

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@en

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@nl

type

Item

label

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@en

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@nl

prefLabel

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@en

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@nl

P1476

FDG PET/CT is useful for detec ...... alignant pleural mesothelioma.

@en

P2093

Futoshi Ishiguro

http://www.w3.org/2001/XMLSchema#string

Kohei Yokoi

http://www.w3.org/2001/XMLSchema#string

Noriyasu Usami

http://www.w3.org/2001/XMLSchema#string

Shota Nakamura

http://www.w3.org/2001/XMLSchema#string

Takayuki Fukui

http://www.w3.org/2001/XMLSchema#string

Tetsuo Taniguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.

Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.

Initial analysis of the international association for the study of lung cancer mesothelioma database.

The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.

Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.

P2888

s11748-013-0345-y

P304

157-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11748-013-0345-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Koji Kawaguchi

P577

2013-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24281913

http://www.w3.org/2001/XMLSchema#string